The present invention relates to Tumor Necrosis Factor Related Ligand (TRELL), a novel member of the tumor necrosis factor family (TNF), modified TRELL, and pharmaceutical compositions comprising them.
Web www.patentalert.com
< TNF-.alpha. binding molecules
< Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme
> Protein belonging to the TNF superfamily involved in signal transduction, nucleic acids encoding same, and methods of use thereof
> Methods for treating neuropathological states and neurogenic inflammatory states and methods for identifying compounds useful therein
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT
